Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arketamine
2. D-ketamine
3. (r)-(+)-ketamine
4. (+)-ketamine
5. 33643-49-1
6. Ketamine, R-
7. Ketamine, (r)-
8. Y2ri13h7vw
9. (2r)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
10. Chebi:580604
11. (2r)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone
12. Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (2r)-
13. J238.629a
14. (2r)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone
15. Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+)-
16. (s) Ketamine
17. Unii-y2ri13h7vw
18. Arketamine [who-dd]
19. Dsstox_cid_28673
20. Dsstox_rid_82943
21. Dsstox_gsid_48747
22. Schembl16104
23. Chembl467505
24. Gtpl9153
25. Dtxsid2048747
26. Pcn-101
27. Tox21_113205
28. Zinc36294079
29. Ncgc00185909-01
30. Cas-33643-49-1
31. Hr-071603
32. Q20707684
33. (2r)-2-(2-chlorophenyl)-2-methylaminocyclohexan-1-one
34. Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (r)-
35. Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (2r)- (9ci)
36. Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+)- (8ci)
37. Rke
Molecular Weight | 237.72 g/mol |
---|---|
Molecular Formula | C13H16ClNO |
XLogP3 | 2.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 2 |
Exact Mass | 237.0920418 g/mol |
Monoisotopic Mass | 237.0920418 g/mol |
Topological Polar Surface Area | 29.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 269 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
(r)-ketamine has known human metabolites that include Norketamine.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
A R-Ketamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of R-Ketamine, including repackagers and relabelers. The FDA regulates R-Ketamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. R-Ketamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of R-Ketamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A R-Ketamine supplier is an individual or a company that provides R-Ketamine active pharmaceutical ingredient (API) or R-Ketamine finished formulations upon request. The R-Ketamine suppliers may include R-Ketamine API manufacturers, exporters, distributors and traders.
click here to find a list of R-Ketamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
R-Ketamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of R-Ketamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right R-Ketamine GMP manufacturer or R-Ketamine GMP API supplier for your needs.
A R-Ketamine CoA (Certificate of Analysis) is a formal document that attests to R-Ketamine's compliance with R-Ketamine specifications and serves as a tool for batch-level quality control.
R-Ketamine CoA mostly includes findings from lab analyses of a specific batch. For each R-Ketamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
R-Ketamine may be tested according to a variety of international standards, such as European Pharmacopoeia (R-Ketamine EP), R-Ketamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (R-Ketamine USP).
LOOKING FOR A SUPPLIER?